Aqemia is a next-gen pharmatech company generating one of the world’s fastest-growing drug discovery pipeline. Our mission is to find a massive number of drug candidates that will become the treatments of tomorrow. Central to our mission are our unique quantum and statistical mechanics algorithms we fuel into an artificial intelligence to design optimized molecules at scale.
Unlike usual AI-based platforms that need experimental data to train on, Aqemia tackles drug discovery projects from their earliest stage by generating its own data with quantum and statistical physics calculations. This major breakthrough makes it possible to push the limits of pharmaceutical R&D and discover therapeutic molecules more rapidly and with a better chance of success. We are a next-gen pharmatech company, massively scaling drug discovery projects.
Location: France, Ile-de-France
Employees: 11-50
Total raised: $63.21M
Founded date: 2019
Investors 2
| Date | Name | Website |
| - | Agoranov | agoranov.c... |
| 27.03.2021 | Elaia Part... | elaia.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 30.01.2024 | Series A | $32.53M | - |
| 24.10.2022 | Series A | $29.58M | - |
| 17.10.2019 | Pre-Seed | $1.11M | - |
Mentions in press and media 10
| Date | Title | Description | Source |
| 26.03.2024 | 10 French startups to watch in 2024 | In 2023 French companies raised €8.4 billion over 410 deals. According to our Annual report, France ... | tech.eu/20... |
| 13.03.2024 | As European dynamism gathers momentum, Elaia and partners do... | Deep tech is on the rise in Europe, fueled in part by the match between AI and a local flavor of mat... | techcrunch... |
| 30.01.2024 | Aqemia Raises Additional €30M in Series A | Aqemia, a Paris, France-based tech-enabled drug discovery company, raised additional €30M in Series ... | finsmes.co... |
| 19.10.2022 | Using “deep physics powered- AI”, Aqemia raises €30 million ... | Aqemia, a Parisian deep tech startup, has raised €30 million in a Series A funding round to further ... | tech.eu/20... |
| 19.10.2022 | Aqemia Raises €30M in Series A Funding | Aqemia, a Paris, France-based pharmatech company, raised €30M in Series A funding. The round was led... | finsmes.co... |
| 19.10.2022 | Aqemia Raises €30 Million to Scale its Deep Physics and AI E... | Aqemia leverages its unique Deep Physics-powered AI to uncover breakthrough drug candidates at scale... | aithority.... |
| 19.10.2022 | Paris-based Aqemia picks up €30 million capital injection to... | - | eu-startup... |
| 06.09.2022 | The 21 most promising healthtech startups of 2022, according... | Ali Ansary, the CEO of Ozette; Ashwini Zenooz, the CEO of Commure; Lucia Huang, the CEO of Osmind; a... | businessin... |
| 17.10.2019 | Aqemia raises €1 million pre-seed round to disrupt drug disc... | Aqemia, a Parisian deep tech startup, has raised €1 million pre-seed round from Elaia to develop its... | tech.eu/br... |
| - | Aqemia | “Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovati... | fastfounde... |